Bis(thio-hydrazide amides) for increasing Hsp70 expression

Details for Australian Patent Application No. 2005306471 (hide)

Owner Synta Pharmaceuticals Corp.

Inventors Barsoum, James

Agent Davies Collison Cave

Pub. Number AU-B-2005306471

PCT Pub. Number WO2006/055747

Priority 60/629,595 19.11.04 US

Filing date 17 November 2005

Wipo publication date 26 May 2006

Acceptance publication date 17 December 2009

International Classifications

A61K 31/16 (2006.01) - Amides, e.g. hydroxamic acids

A61K 31/165 (2006.01) - having aromatic rings, e.g. colchicine, atenolol, progabide

A61K 31/277 (2006.01)

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 25/08 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

Event Publications

31 May 2007 PCT application entered the National Phase

  PCT publication WO2006/055747 Priority application(s): WO2006/055747

17 December 2009 Application Accepted

  Published as AU-B-2005306471

15 April 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005306472-Method for the preparation of Sevoflurane

2005306470-Integrated idea management method and software with protection mechanism